Type C mutation of nucleophosmin 1 acute myeloid leukemia: Consequences of intrinsic disorder.


Journal

Biochimica et biophysica acta. General subjects
ISSN: 1872-8006
Titre abrégé: Biochim Biophys Acta Gen Subj
Pays: Netherlands
ID NLM: 101731726

Informations de publication

Date de publication:
08 2022
Historique:
received: 03 02 2022
revised: 09 04 2022
accepted: 13 05 2022
pubmed: 22 5 2022
medline: 3 6 2022
entrez: 21 5 2022
Statut: ppublish

Résumé

Nucleophosmin 1 (NPM1) protein is a multifunctional nucleolar chaperone and its gene is the most frequently mutated in Acute Myeloid Leukemia (AML). AML mutations cause the unfolding of the C-terminal domain (CTD) and the protein delocalizing in the cytosol (NPM1c+). Marked aggregation endowed with an amyloid character was assessed as consequences of mutations. Herein we analyzed the effects of type C mutation on two protein regions: i) a N-terminal extended version of the CTD, named Cterm_mutC and ii) a shorter polypeptide including the sequences of the second and third helices of the CTD, named H2_mutC. Both demonstrated able to self-assembly with different kinetics and conformational intermediates and to provide fibers presenting large flexible regions. The present study adds a new piece of knowledge to the effects of AML-mutations on structural biology of Nucleophosmin 1, that could be exploited in therapeutic interventions targeting selectively NPMc+.

Sections du résumé

BACKGROUND
Nucleophosmin 1 (NPM1) protein is a multifunctional nucleolar chaperone and its gene is the most frequently mutated in Acute Myeloid Leukemia (AML). AML mutations cause the unfolding of the C-terminal domain (CTD) and the protein delocalizing in the cytosol (NPM1c+). Marked aggregation endowed with an amyloid character was assessed as consequences of mutations.
SCOPE
Herein we analyzed the effects of type C mutation on two protein regions: i) a N-terminal extended version of the CTD, named Cterm_mutC and ii) a shorter polypeptide including the sequences of the second and third helices of the CTD, named H2_mutC.
MAJOR CONCLUSIONS
Both demonstrated able to self-assembly with different kinetics and conformational intermediates and to provide fibers presenting large flexible regions.
GENERAL SIGNIFICANCE
The present study adds a new piece of knowledge to the effects of AML-mutations on structural biology of Nucleophosmin 1, that could be exploited in therapeutic interventions targeting selectively NPMc+.

Identifiants

pubmed: 35597503
pii: S0304-4165(22)00091-5
doi: 10.1016/j.bbagen.2022.130173
pii:
doi:

Substances chimiques

Amyloidogenic Proteins 0
NPM1 protein, human 0
Nuclear Proteins 0
Nucleophosmin 117896-08-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

130173

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Sara La Manna (S)

Department of Pharmacy, University of Naples "Federico II", 80131 Naples, Italy.

Daniele Florio (D)

Department of Pharmacy, University of Naples "Federico II", 80131 Naples, Italy.

Concetta Di Natale (C)

Interdisciplinary Research Centre on Biomaterials (CRIB), Department of Ingegneria Chimica, dei Materiali e della Produzione Industriale (DICMAPI), Italy; Istituto Italiano di Tecnologia, University of Naples "Federico II", Largo Barsanti e Matteucci 53, Naples 80125, Italy.

Elena Lagreca (E)

Interdisciplinary Research Centre on Biomaterials (CRIB), Department of Ingegneria Chimica, dei Materiali e della Produzione Industriale (DICMAPI), Italy; Istituto Italiano di Tecnologia, University of Naples "Federico II", Largo Barsanti e Matteucci 53, Naples 80125, Italy.

Teresa Sibillano (T)

Institute of Crystallography (IC), National Research Council, 70125 Bari, Italy.

Cinzia Giannini (C)

Institute of Crystallography (IC), National Research Council, 70125 Bari, Italy.

Daniela Marasco (D)

Department of Pharmacy, University of Naples "Federico II", 80131 Naples, Italy. Electronic address: daniela.marasco@unina.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH